Skip to main content

Pharmacy

By Michelle Andrews, Kaiser Health News | 03:10 pm | October 03, 2017
Mavyret's price tag of $26,400 for a course of treatment is significantly below that of other hepatitis C drugs whose sticker price ranges from about $55,000 to $95,000.
By Jay Hancock, Kaiser Health News | 12:16 pm | October 02, 2017
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
By Jeff Lagasse | 04:17 pm | September 29, 2017
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs could lead to even greater cost
By Beth Jones Sanborn | 11:10 am | September 26, 2017
Aegerion failed to inform providers of drug's risks outside prescribed usage, conspired to violate HIPAA, improperly distributed drug, DOJ says.
By Jeff Lagasse | 12:04 pm | September 21, 2017
The Biosimilars Council has urged CMS to revisit their payment and coding policy and provide unique billing code and payment rate for these drugs.
By Jeff Lagasse | 03:56 pm | September 19, 2017
Most say payers should increase prices for those with poor health habits and offer affordable catastrophic health insurance plans.
By Beth Jones Sanborn | 03:44 pm | September 19, 2017
Proceeds used to buy a $3.6 million mansion formerly owned by Dwayne "the Rock" Johnson, a Ferrari, two Rolls Royces, other luxury autos, DOJ said.
By Mike Miliard | 11:50 am | September 18, 2017
By giving patients control over their data, the technology could enable better privacy protections, more efficiency and easier information exchange.
By Sarah Jane Tribble, Kaiser Health News | 10:43 am | September 18, 2017
A seemingly minor detail about 340B discount program in ACA has left rural pharmacists struggling to keep medicines in stock.
By Sarah Jane Tribble, Kaiser Health News | 05:12 pm | September 13, 2017
The agency confirmed FDA Commissioner Scott Gottlieb's modernization plan is part of a larger effort to increase competition and decrease drug prices.